Acknowledging the kind of traction gained by this market, Market Research Future (MRFR) in its recently published a study report asserts that the Global 3D Bioprinting Market is projected to accrue voluminously by 2023 registering a phenomenal CAGR of 25% during the review period (2017 to 2023). Currently, the 3D Bioprinting is used to print tissues and organs to help research drugs and pills.
3D Bioprinting Market – Competitive Landscape
Key market contributors are
- Stratasys Ltd. (U.S.)
- ORGANOVO HOLDINGS, INC. (U.S.)
- Aspect Biosystems Ltd. (Canada)
- FATHOM (U.S.)
- CELLINK AB (Sweden)
- Bio3D Technologies (Singapore)
- Materialise (U.S.)
- Allevi (U.S.)
- ENVISIONTEC, INC. (Germany)
Industry/ Innovation /Related News:
March 25th, 2019
CD3D, a Poland-based 3D printer company, announced the launch of the largest open 3D bioprinting cluster in Europe. Located in Lodz, Poland, the cluster consists of 21 SKAFFOSYS bioprinter units. The units will be leveraged upon to pursue R&D activities in the biomedical arena.
Get Free Sample @ https://www.marketresearchfuture.com/sample_request/869
March 22nd, 2019
Allevi, a Philly-based 3D bioprinting company, introduced the innovative Skin Bioink Kit. The kit needs to be used in conjunction with its 3D bioprinters to create skin patches. The launch of the product is aimed at allowing tissue engineers to design multi-layered skin patches that are similar to natural human skin.
3D Bioprinting Market – Highlights
It is reported that the growing demand for organ transplantation is expected to push the growth of the 3D Bioprinting Market. Also, rising occurrences of organ failure owing to accidents, diseases, and old age have created a massive gap for the functioning of organs. The emergence of 3D bioprinting can fill-in the gap by producing them on a massive scale.
Furthermore, the cost-effective nature of the technology is expected to drive the market demand as well. Opportunities related to the manufacturing of pills for the pharmaceutical sector and for producing prosthetics and implants is anticipated to augment the market too. The rising investment for R&D activities is expected to broaden the potential of the technology and subsequently the market growth.
Entry of various startup companies such as Nano 3D Bioscience and Cyfuse Biomedical in the industry is expected to open up new avenues for expansion. Prominent companies can gain entry by acquiring small and medium startups and gain an enviable position in the market.
3D Bioprinting Market – Segmentation
The 3D Bioprinting Market is segmented by technology, material, application, and end-user.
By technology, microextrusion bioprinting held close to 31.7% share in 2017, followed by inkjet 3D bioprinting (25.1%), laser-assisted bioprinting (20.6%), magnetic 3D bioprinting (13.7%), and others (8.9%). The microextrusion bioprinting segment is projected to register a whopping 25.24% CAGR during the forecast period. This can be attributed to its extensive applications in bioprinting. On the other hand, inkjet 3D bioprinting can exhibit 26.44% CAGR owing to be a viable alternative for scaffold fabrication.
By material, living cells accounted for 39.7% share in 2017, followed by hydrogels (30.8%), extracellular matrices (21.0%), and others (8.5%). Living cells are predicted to exhibit 25.05% CAGR during the forecast period thanks to the expedited production process of micro building blocks. The blocks play a vital role in repairing damaged tissues. Hydrogels, on the other hand, can generate close to USD 652.54 million by 2023 at a CAGR of 26.63% during the forecast period.
Among applications, research applications accounted for 73% share in 2017, followed by clinical applications with 27% share in the same year. Research applications can exhibit 24.74% CAGR till 2023 owing to applications in 3D cell culture and regenerative medicine. Clinical applications, on the other hand, can generate close to USD 507.55 million by 2023, at a 24.19% CAGR during the assessment period.
Among end-users, pharmaceutical & biotechnology companies accounted for 52.6% share in 2017, followed by research organizations & academic institutes (33.3%), and others (14.1%). Pharmaceutical & biotechnology companies are projected to display 24.98% CAGR till 2023 owing to the trend in personalized medicines.
3D Bioprinting Market – Regional Analysis
Geographically, the market has been segmented into the Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa (MEA).
The Americas hold the maximum share owing to a well-structured healthcare sector and heavy investment both by the government and the private players. A large base of patient population waiting for transplantation is also a market booster. Healthcare expenditure due to a rise in disposable income and the presence of significant market players are proving to be significant contributors.
Europe is the second largest market with a cluster of developed countries such as France, Germany and the U.K. who are spending heavily on the technology and is always eager to innovate.
APAC is the fastest growing region with continuously growing population and burgeoning healthcare sector in developing countries such as China and India. According to the Indian Brand Equity Foundation in 2017, the Indian market is deemed to grow with an astonishing CAGR of 22.87% by 2020 and touch USD 280 billion.
MEA is unlikely to get a huge boost in 3D Bioprinting Market owing to the presence of several poor countries in the region. Qatar, Kuwait, Saudi Arabia, and Dubai are the few countries with advanced healthcare infrastructure and interested in research investments.
Major Table Of Contents
1 Report Prologue
2 Executive Summary
3 Market Introduction
4 Research Methodology
5 Market Dynamics
6 Market Factor Analysis
7 Global 3D Bioprinting Market, by Technology
8 Global 3D Bioprinting Market, by Material
9 Global 3D Bioprinting Market, by Application
10 Global 3D Bioprinting Market, by End User
11 Global 3D Bioprinting Market, by Region
12 Competitive Landscape
13 Company Profiles
15 List of Tables
16 List of Figures
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312